Red Tortoise LLC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.6K Hold
207
0.01% 153
2025
Q4
$28.5K Hold
207
0.01% 158
2025
Q3
$26.5K Hold
207
0.01% 165
2025
Q2
$25K Hold
207
0.01% 149
2025
Q1
$23.1K Hold
207
0.01% 145
2024
Q4
$20.1K Hold
207
0.01% 164
2024
Q3
$23.8K Hold
207
0.01% 150
2024
Q2
$22K Hold
207
0.01% 149
2024
Q1
$20K Hold
207
0.01% 148
2023
Q4
$20.9K Hold
207
0.01% 130
2023
Q3
$21.1K Hold
207
0.01% 124
2023
Q2
$20.9K Hold
207
0.01% 129
2023
Q1
$19K Hold
207
0.01% 139
2022
Q4
$18.8K Buy
+207
New +$17.4K 0.01% 181
2021
Q4
Sell
-207
Closed -$16K 371
2021
Q3
$16K Buy
+207
New +$18.6K 0.01% 184

Other funds holding NVS

Red Tortoise LLC's NVS Position: Q1 2026 in Review

Red Tortoise LLC held its Novartis (NVS) position steady in Q1 2026 at 207 shares worth $31.6K. The position accounts for 0.01% of the portfolio, ranked #153.

Red Tortoise LLC first reported a position in NVS in Q3 2021 and has held it in 15 quarters since. 1,599 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Red Tortoise LLC held 207 shares of Novartis worth $31.6K as of Q1 2026.
  • Red Tortoise LLC left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #153 holding.
  • Red Tortoise LLC first reported a position in Novartis in Q3 2021 and has held it in 15 quarters since.
  • 1,599 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.